0001279569-19-000560.txt : 20190313 0001279569-19-000560.hdr.sgml : 20190313 20190313164302 ACCESSION NUMBER: 0001279569-19-000560 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20190313 FILED AS OF DATE: 20190313 DATE AS OF CHANGE: 20190313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOVASC INC CENTRAL INDEX KEY: 0001399708 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36458 FILM NUMBER: 19678717 BUSINESS ADDRESS: STREET 1: 2135 13700 Mayfield place CITY: RICHMOND STATE: A1 ZIP: 00000 BUSINESS PHONE: 604-270-4344 MAIL ADDRESS: STREET 1: 2135 13700 Mayfield place CITY: RICHMOND STATE: A1 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Medical Ventures Corp DATE OF NAME CHANGE: 20070516 6-K 1 neovasc6k.htm FORM 6-K
 

 

Securities and Exchange Commission

washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

 

 

For the month of

 March   2019

 

Commission File Number

 001-36458    

 

Neovasc Inc.

(Translation of registrant’s name into English)

 

Suite 5138 - 13562 Maycrest Way

Richmond, British Columbia, Canada, V6V 2J7

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

 

Form 20-F

 ☒

 

Form 40-F

  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):          

 

            Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):           

 

 

 

 

 
 
 

 

DOCUMENTS INCLUDED AS PART OF THIS REPORT

 

 

Document    
     
Document 1   News Release dated March 13, 2019 - Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21
     

 

 
 

DOCUMENT 1

 

 

 

Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21

Conference Call Scheduled for 4:30pm Eastern Time

NASDAQ, TSX: NVCN

VANCOUVER, March 13, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that, due to the public offering of common stock announced on March 12, 2019, it will now report financial results for the year ended December 31, 2018 and host a conference call and webcast at 4:30 pm Eastern Time on Thursday, March 21, 2019.

Conference Call & Webcast

Thursday, March 21st @ 4:30pm Eastern Time
Domestic: 877-407-9208
International: 201-493-6784
Passcode: 13687733
Webcast:  http://public.viavid.com/index.php?id=133322 

 

About Neovasc Inc. 
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe. For more information, visit: www.neovasc.com.

CisionView original content:http://www.prnewswire.com/news-releases/neovasc-to-announce-year-ended-december-31-2018-financial-results-on-thursday-march-21-300812005.html

SOURCE Neovasc Inc.

View original content: http://www.newswire.ca/en/releases/archive/March2019/13/c2466.html

%CIK: 0001399708

For further information: Chris Clark, Chief Financial Officer, Neovasc Inc., 604 248-4138, cclark@neovasc.com; Jeremy Feffer, LifeSci Advisors, LLC, 212-915-2568

CO: Neovasc Inc.

CNW 16:30e 13-MAR-19

 

 
 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Neovasc Inc.
  (Registrant)

 

Date:

  

 

March 13, 2019

 

 

 

By:

 

/s/ Chris Clark

 

Name: Chris Clark

Title: Chief Financial Officer

 

           

 

 

 GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 3 image_002.jpg GRAPHIC begin 644 image_002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#V+68YKO5; M>TCNY;8?9Y959'*@."H!/J!D\5N+G:,G)QR?6LS5M*AU%HFDDFC.#$WEL!N1 ?L94\=#@5IJH50HZ 8%8TXM3DWU.BK.+I02Z>7ZG_V0$! end